Medicare Enrolled
Dr. Shahrooz Eshaghian, M.D.
Hematology & Oncology · Los Angeles, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Eshaghian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eshaghian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Eshaghian
Dr. Shahrooz Eshaghian is a hematology & oncology specialist in Los Angeles, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Eshaghian performed 161,825 Medicare services across 8,832 unique beneficiaries.
Between the years covered by Open Payments, Dr. Eshaghian received a total of $19,817 from 75 pharmaceutical and/or device companies across 460 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Eshaghian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in CA
$19,817 industry payments
Medicare Practice Summary
Medicare Utilization ↗161,825
Medicare services
Top 4% in CA for hematology & oncology
8,832
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~8,990 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
90,000 | $1 | $3 |
| Denosumab injection (Prolia/Xgeva) | 22,762 | $18 | $69 |
| Pembrolizumab injection (Keytruda) | 11,437 | $43 | $165 |
| Iron infusion (Monoferric) | 7,800 | $16 | $62 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
5,419 | $67 | $244 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,146 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,093 | $108 | $421 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,564 | $8 | $23 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
1,519 | $4 | $17 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,261 | $8 | $16 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,198 | $102 | $364 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
1,154 | $8 | $25 |
| Liver function blood test panel | 1,140 | $8 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,000 | $12 | $48 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
763 | $152 | $591 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
715 | $148 | $567 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
438 | $13 | $40 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
406 | $26 | $102 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
370 | $121 | $468 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
367 | $1 | $4 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
364 | $15 | $45 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
349 | $1 | $2 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
340 | $57 | $230 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
335 | $14 | $44 |
| Anti-nausea injection (Aloxi/palonosetron) | 318 | $1 | $2 |
| Coagulation function measurement, d-dimer; quantitative | 317 | $10 | $31 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
262 | $19 | $57 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
238 | $6 | $18 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
237 | $95 | $428 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
218 | $16 | $50 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
214 | $9 | $27 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
212 | $17 | $51 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
207 | $4 | $14 |
| PSA test (prostate cancer screening) | 200 | $18 | $63 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
188 | $78 | $249 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
175 | $25 | $77 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
171 | $67 | $261 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
128 | $5 | $14 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
122 | $1 | $4 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
120 | $7 | $20 |
| New patient office visit, complex (60-74 min) | 119 | $187 | $720 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
106 | $26 | $98 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 88 | $76 | $289 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
77 | $30 | $117 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
46 | $30 | $116 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
46 | $12 | $44 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
31 | $10 | $29 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
16 | $13 | $40 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
15 | $10 | $32 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
14 | $4 | $13 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
61.2% high complexity
25.9% medium
12.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,817
Total received (2018-2024)
Avg $2,831/year across 7 years
Top 21% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
460
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,911 (55.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,747 (44.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$159 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,893
2023
$6,243
2022
$2,656
2021
$267
2020
$1,452
2019
$3,709
2018
$597
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BeiGene USA, Inc.
$1,650
AstraZeneca Pharmaceuticals LP
$335
Daiichi Sankyo Inc.
$313
Novartis Pharmaceuticals Corporation
$217
Astellas Pharma US Inc
$209
E.R. Squibb & Sons, L.L.C.
$181
Janssen Biotech, Inc.
$178
Incyte Corporation
$115
PFIZER INC.
$113
SOBI, INC
$96
GlaxoSmithKline, LLC.
$91
Genentech USA, Inc.
$86
Regeneron Healthcare Solutions, Inc.
$78
Lilly USA, LLC
$76
ABBVIE INC.
$75
Takeda Pharmaceuticals U.S.A., Inc.
$74
Merck Sharp & Dohme LLC
$73
JAZZ PHARMACEUTICALS INC.
$72
Eisai Inc.
$65
Apellis Pharmaceuticals, Inc.
$60
PROGENICS PHARMACEUTICALS, INC.
$60
Karyopharm Therapeutics Inc.
$55
EMD Serono, Inc.
$43
Mirati Therapeutics, Inc.
$42
Celgene Corporation
$38
Janssen Pharmaceuticals, Inc
$33
Myriad Genetic Laboratories, Inc.
$32
ARRAY BIOPHARMA INC
$30
Sumitomo Pharma America, Inc.
$30
Deciphera Pharmaceuticals Inc.
$28
Adaptive Biotechnologies Corporation
$26
Novocure Inc.
$26
Blueprint Medicines Corporation
$25
PharmaEssentia USA Corporation
$24
Alexion Pharmaceuticals, Inc.
$24
Helsinn Therapeutics (U.S.), Inc.
$24
ADC Therapeutics America, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
Emmaus Medical, Inc.
$22
Gilead Sciences, Inc.
$21
TerSera Therapeutics LLC
$20
SpringWorks Therapeutics, Inc.
$20
Ipsen Biopharmaceuticals, Inc
$19
Rigel Pharmaceuticals, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$16
TAIHO ONCOLOGY, INC.
$14
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$3,187
Dova Pharmaceuticals
$2,868
Bayer HealthCare Pharmaceuticals Inc.
$1,894
BeiGene USA, Inc.
$1,688
Kite Pharma, Inc.
$1,624
Janssen Biotech, Inc.
$981
Daiichi Sankyo Inc.
$626
E.R. Squibb & Sons, L.L.C.
$456
Genentech USA, Inc.
$455
PFIZER INC.
$396
Novartis Pharmaceuticals Corporation
$387
AstraZeneca Pharmaceuticals LP
$376
Amgen Inc.
$349
Astellas Pharma US Inc
$290
ABBVIE INC.
$273
GENZYME CORPORATION
$265
Merck Sharp & Dohme LLC
$225
GlaxoSmithKline, LLC.
$222
Incyte Corporation
$203
Celgene Corporation
$196
Takeda Pharmaceuticals U.S.A., Inc.
$180
Merck Sharp & Dohme Corporation
$177
Janssen Scientific Affairs, LLC
$145
SOBI, INC
$119
Eisai Inc.
$114
Regeneron Healthcare Solutions, Inc.
$107
Karyopharm Therapeutics Inc.
$89
Mirati Therapeutics, Inc.
$84
TerSera Therapeutics LLC
$81
Bayer Healthcare Pharmaceuticals Inc.
$80
Lilly USA, LLC
$76
JAZZ PHARMACEUTICALS INC.
$72
Deciphera Pharmaceuticals Inc.
$70
ADC Therapeutics America, Inc.
$69
Ipsen Biopharmaceuticals, Inc
$66
PharmaEssentia USA Corporation
$64
Apellis Pharmaceuticals, Inc.
$60
PROGENICS PHARMACEUTICALS, INC.
$60
Seagen Inc.
$53
ARRAY BIOPHARMA INC
$52
Sun Pharmaceutical Industries Inc.
$51
Myriad Genetic Laboratories, Inc.
$49
Blueprint Medicines Corporation
$47
Alexion Pharmaceuticals, Inc.
$47
CTI BioPharma Corp.
$46
EMD Serono, Inc.
$43
Global Blood Therapeutics, Inc.
$42
Stemline Therapeutics Inc.
$41
Edwards Lifesciences Corporation
$41
TAIHO ONCOLOGY, INC.
$35
Janssen Pharmaceuticals, Inc
$33
Shire North American Group Inc
$32
MACROGENICS, INC.
$31
Sumitomo Pharma America, Inc.
$30
Mylan Pharmaceuticals Inc.
$29
Sobi, Inc
$29
Pharmacyclics LLC, An AbbVie Company
$29
Organon LLC
$28
Adaptive Biotechnologies Corporation
$26
Novocure Inc.
$26
Pharmacosmos Therapeutics Inc.
$25
ImmunoGen, Inc.
$24
Helsinn Therapeutics (U.S.), Inc.
$24
Pulmonx Corporation
$23
Dendreon Pharmaceuticals LLC
$22
PUMA BIOTECHNOLOGY, INC.
$22
Emmaus Medical, Inc.
$22
Teva Pharmaceuticals USA, Inc.
$21
Pharmacyclics LLC, an AbbVie Company
$21
SpringWorks Therapeutics, Inc.
$20
Rigel Pharmaceuticals, Inc.
$19
Progenics Pharmaceuticals, Inc.
$18
MENARINI SILICON BIOSYSTEMS, INC.
$16
R-Pharm US LLC
$16
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$12
Top 3 companies account for 40.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALUNBRIG · AUGTYRO · AYVAKIT · Aliqopa · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CAMZYOS · CELLSEARCH · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ENHERTU · EPKINLY · ERLEADA · EVENITY · Edwards SAPIEN 3 Transcatheter Heart Valve · Elahere · Empaveli · Endari · Enhertu · Erleada · FASENRA · FRUZAQLA · Fabhalta · Fulphila · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Ixempra · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUPRON DEPOT · Lenvima · LifeVest · MARGENZA · MEKINIST · MONOFERRIC · MYRISK · NINLARO · NUCALA · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROVENGE · PYLARIFY · Padcev · Prolia · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SYNAGIS · Stivarga · TAGRISSO · TECENTRIQ · TEVIMBRA · TIVDAK · Tazverik · Tecartus · Tecentriq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XPOVIO · XTANDI · Xospata · Xtandi · YONSA · ZEJULA · ZEPHYR DELIVERY CATHETER · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
355
Per 100K population
3.6
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - WEST LA
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Eshaghian is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with consulting-driven industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Eshaghian experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Eshaghian performed 90,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eshaghian receive payments from pharmaceutical companies?
Yes. Dr. Eshaghian received a total of $19,817 from 75 companies across 460 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eshaghian's costs compare to other hematology & oncology specialists in Los Angeles?
Dr. Eshaghian's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eshaghian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Los Angeles
Browse hematology & oncology specialists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Dova Pharmaceuticals Payments to Doctors
See all physicians who received payments from Dova Pharmaceuticals.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology